Lansoprazole Capsule, Delayed Release
Product Images NDC 60687-123

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 60687-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15 mg Blister

Labels for Lansoprazole delayed-release capsules, USP 15 mg, from American Health Packaging. Each label displays the product name, strength, dosage form, a barcode, placeholder text for expiration date and lot number, and the labeler's location in Columbus, Ohio.*

FDA Label Image

15 mg Carton

Lansoprazole 15 mg delayed-release capsules label from American Health Packaging. The label states the product contains 30 capsules (3 x 10), includes storage instructions, usage warnings, and distributor information. It identifies the capsules as containing lansoprazole USP in enteric-coated pellets and emphasizes prescription-only status.*

FDA Label Image

30 mg Blister

Label for Lansoprazole 30 mg delayed-release capsules, USP, by American Health Packaging. Each label includes the product name, strength, dosage form, lot number (123456), and expiry date (01/16). The labels are designed for multiple units, shown in a vertical strip format with barcodes and manufacturing details.*

FDA Label Image

30 mg Carton

Lansoprazole 30 mg delayed-release capsules, USP, pack of 100 capsules (10 x 10) by American Health Packaging. The label includes NDC 60687-123-01, dosage form as oral capsules, and pharmacist instructions to dispense with a medication guide. Storage information and distributor details from American Health Packaging in Columbus, Ohio, are also present.*

FDA Label Image

Ahp11121

Two Lansoprazole delayed-release capsules shown against a gray background with measurement markings. Each capsule is half pink and half green. The pink half of the top capsule is imprinted with "R D Y" and the green half is imprinted with "LAN". The bottom capsule shows the same color scheme without visible markings. The capsules are solid, smooth, and elliptical in shape.*

FDA Label Image

Ahp12301

Capsules of Lansoprazole, delayed release, with one half pink and the other half black. One capsule is imprinted with "RDY" on the pink side and "399" on the black side in white ink. The capsules are oral dosage form. Labeler is American Health Packaging.*

FDA Label Image

Figure1 (Figure 1)

A line graph showing mean severity of day heartburn over time for evaluable patients, comparing placebo with Lansoprazole 15 mg QD and 30 mg QD. The y-axis represents mean severity of day heartburn (0 to 3 scale), and the x-axis shows days from start of treatment, ranging from -5 to 60 days.*

FDA Label Image

Figure2 (Figure 2)

A line graph showing the mean severity of night heartburn over time for evaluable patients treated with placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The y-axis represents severity from 0 to 1.8, and the x-axis shows days from start of treatment up to 60 days. The graph compares symptom changes across the three groups.*

FDA Label Image

Structure (Structure)

Chemical structure of lansoprazole, showing the molecular arrangement including a benzimidazole ring, sulfinyl linkage, and substituted pyridine ring with trifluoromethoxy and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.